Moderna Inc (NASDAQ:MRNA)

70.52
Delayed Data
As of Sep 29
 -0.03 / -0.04%
Today’s Change
13.53
Today|||52-Week Range
95.21
+260.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$27.4B

Company Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Contact Information

Moderna, Inc.
200 Technology Square
Cambridge Massachusetts 02139
P:(617) 714-6500
Investor Relations:

Employees

Shareholders

Mutual fund holders27.27%
Other institutional18.91%
Individual stakeholders18.54%

Top Executives

Stéphane BancelChief Executive Officer & Director
Stephen HogePresident
David W. MelineChief Financial Officer
Tal ZaksChief Medical Officer
Juan AndresChief Technical Operations & Quality Officer